Method For Treating Post-traumatic Stress Disorder

Abstract

The present disclosure provides compositions containing ketamine and methods of using those compositions for the treatment of post-traumatic stress disorder. Also provided herein is a pharmaceutical composition that comprises esketamine and a pharmaceutically acceptable carrier, excipient or diluent, for use in treatment of PTSD. In some aspects, the pharmaceutical composition is for intranasal or intravenous administration. In some aspects, the pharmaceutical composition is for use in a method of treating PTSD in a subject. In some aspects, the pharmaceutical composition is for use in a method of treating major depressive disorder in a subject that is co-morbid with the PTSD.


Claims
Download PDF
Document Preview
Document History
  • Publication: Oct 16, 2014
  • Application: Apr 14, 2014
    WO US 2014/0033997 W
  • Priority: Dec 13, 2013
    US US 201361915947 P
  • Priority: Apr 12, 2013
    US US 201361811681 P

Download Citation


Sign in to the Lens

Feedback